These results, along with a preceding report demonstrating that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,2 support the idea of focusing on ACKR3 as a novel strategy to modulate the opioid process, which could open new therapeutic avenues for opioid-relevant Issues. Long-term discomfort is complicated, and https://jinnahi305ubh9.wikicorrespondent.com/user